In addition, we also detected anti-IFN-γ IgM using the same method, and no significant difference in serum anti-IFN-γ IgM levels between SLE patients with severe infections (0.41 ± 0.27) and those without severe infections (0.35 ± 0.18). This evidence concerns the gene CD40LG and systemic lupus erythematosus.